We welcome blogs on issues across Science, Technology, Research and Innovation, and on the activities of the Foundation. To publish a blog on this site, please email Gavin Costigan (gavin.costigan@foundation.org.uk).
Note: The Foundation for Science and Technology is strictly neutral. Any views expressed in these blogs are those of the authors and not of the Foundation.
In this blog, Alyssa Gilbert, Director of Policy & Translation at the Grantham Institute, Imperial College, previews the COP27 climate change meeting, which is being held in Sharm El Sheikh in November 2022, and the possibility of progress in climate finance, adaptation and loss & damage.
Read MoreOn 4th August 2022, the House of Lords Science and Technology Committee published a report "Science and technology superpower": more than a slogan? In this blog, Lord Holmes of Richmond sets out some of the key findings and recommendations.
Read MoreIn this blog, Dr Carlanne Stone outlines the experience of taking part in the 2021 Foundation Future Leaders scheme - and encourages others to apply for next year.
Read MoreIn this blog, Chloe Davies discusses the Nuclear Energy Regulated Asset Base model introduced by the Government, what this means for energy bills and for achieving Net Zero emissions.
Read MoreIn this blog, Indro Mukerjee, Chief Executive of Innovate UK, gives a foretaste of Innovate UK's Plan for Action, soon to be published.
Read MoreIn this blog, Jules Payne, CEO of Heart UK - The Cholesterol Charity, argues that patients need to be fully aware of what clinical trials are seeking to achieve, and the opportunities to participate in them. Patient groups can help in ensuring clinical trial information is written in a way accessible to those who will benefit from them - patients.
Read MoreIn this latest blog, Daniel Swerdlow, Senior Medical Director at Silence Therapeutics UK, discusses how healthcare data can be used to improve the success of clinical trials by optimising patient selection.
Read MoreProfessor Sir Gordon Duff, former Chair of the MHRA and current head of the Science and Technology Advisory Board at Silence Therapeutics, discusses the need to boost early-phase clinical research and ensure the UK continues to be an attractive and competitive destination for companies to design, trial and develop novel medicines for common and rare diseases.
Read MoreKeyne Walker, Policy Officer at the Royal Academy of Engineering, discusses a systems approach to reaching Net Zero - what it looks like in practice and the implications for policymaking
Read MoreDr Tom Dolan explores the potential of National Infrastructure as a leverage point for a Net Zero future, and outlines what this transformation could entail.
Read More